Breast cancer remains one of the most prevalent malignancies worldwide, encompassing a wide spectrum of subtypes and therapeutic challenges. While studies utilizing large groups of patients are ...

Please provide your email address to receive an email when new articles are posted on . Lobular breast cancer would be the seventh most common malignancy among women in the U.S. if ranked separately ...

Objective: To evaluate the positive predictive value (PPV) of amorphous calcifications and to analyze the imaging variables that could alter the risk of malignancy associated with this finding.

While the ductal subtype accounts for 70% to 80% of all breast cancers and the lobular subtype accounts for just 10% to 15%, the lobular subtype is more common among peri- and postmenopausal women, is ...

A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new findings from a multi-center phase 2 clinical trial led by Northwestern ...

A drug already approved to treat menopause symptoms may also lower the risk of invasive breast cancer, according to new research from a phase 2 clinical trial led by Northwestern Medicine. The study, ...

Duavee slowed cell growth in women with non-invasive breast cancer Already approved for menopausal symptoms, Duavee didn’t affect quality of life in participants May offer safe option for women with ...

A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new findings from a multi-center phase 2 clinical trial led by Northwestern ...

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted ...

As Breast Cancer Awareness Month kicks off, the Breast Center at HCA Florida Fort Walton-Destin Hospital is emphasizing the critical importance of early detection in the fight against breast cancer.